1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Interest in the Development of Advanced Medicines and Vaccines
4.2.2 Increasing Demand for Biologics
4.3 Market Restraints
4.3.1 Complexity of Upstream and Downstream Processing and Strict Regulations
4.3.2 High Cost of Raw Materials
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Instruments
5.1.2 Consumables
5.2 By Application
5.2.1 Antibiotics
5.2.2 Recombinant Proteins
5.2.3 Biosimilars
5.2.4 Other Applications
5.3 By Type
5.3.1 Substrate Analysis
5.3.2 Metabolite Analysis
5.3.3 Concentration Detection
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 4BioCell GmbH & Co. KG
6.1.2 Agilent Technologies
6.1.3 F. Hoffmann-La Roche AG
6.1.4 Groton Biosystems
6.1.5 Kaiser Optical Systems Inc.
6.1.6 Nova Biomedical Corporation
6.1.7 Randox Laboratories Ltd
6.1.8 Sartorious AG
6.1.9 SYSBIOTECH GmbH
6.1.10 Thermo Fisher Scientific
6.1.11 YSI Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS